Title : Design and evaluation of floating dosage forms as controlled release modules

Type of Material: Thesis
Title: Design and evaluation of floating dosage forms as controlled release modules
Researcher: Dasari, Varun
Guide: Rao, Chandu Babu
Mukkanti, K.
Department: Faculty of Pharmaceutical Sciences
Publisher: Jawaharlal Nehru Technological University, Hyderabad
Place: Hyderabad
Year: 2012
Language: English
Subject: Controlled
Design
Dosage
Evaluation
Floating
Modules
Dissertation/Thesis Note: PhD; Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad; 2012
Fulltext: Shodhganga

00000000ntm a2200000ua 4500
001453857
003IN-AhILN
0052024-07-01 15:57:42
008__240701t2012||||ii#||||g|m||||||||||eng||
035__|a(IN-AhILN)th_453857
040__|aJNTU_500028|dIN-AhILN
041__|aeng
100__|aDasari, Varun|eResearcher
110__|aFaculty of Pharmaceutical Sciences|bJawaharlal Nehru Technological University, Hyderabad|dHyderabad|ein|0U-0017
245__|aDesign and evaluation of floating dosage forms as controlled release modules
260__|aHyderabad|bJawaharlal Nehru Technological University, Hyderabad|c2012
300__|a363 p.|dNone|c-
500__|aReferences p.349-363
502__|cFaculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad|d2012|bPhD
520__|aHuman immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS), commonly referred to as HIV/AIDS, constitute one of the most serious infectious disease challenges to public health globally, and has had a crippling effect in certain parts of the world. There are currently 33.2 million people living with HIV/AIDS globally. newlineThe people suffering with HIV infection need to take more number of drugs with repeated administration. This is because of the structural changes of the viral gene inside the cell and less biological half lives of these drugs. This causes the patient non compliance and some time may lead to the severe adverse affects. Sustaining the drug release of these drugs may improve the patient compliance, reduce the plasma drug fluctuations and limit the adverse reactions. newlineIn the present study five anti retroviral drugs such as Stavudine, lamivudine, Lopinavir, Ritonavir and Valganciclovir were selected to develop the extended release formulations using v
653__|aControlled
653__|aDesign
653__|aDosage
653__|aEvaluation
653__|aFloating
653__|aModules
700__|aRao, Chandu Babu|eGuide
700__|aMukkanti, K.|eGuide
856__|uhttp://shodhganga.inflibnet.ac.in/handle/10603/19041|yShodhganga
905__|afromsg

User Feedback Comes Under This section.